
Results
12
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
12 companies
Hospital Corporation of China
Market Cap: HK$932.3m
An investment holding company, owns, operates, and manages hospitals in the People’s Republic of China.
3869
HK$6.83
7D
1.5%
1Y
43.8%
Gaush Meditech
Market Cap: HK$1.2b
Engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.
2407
HK$8.51
7D
-8.9%
1Y
-24.8%
Sinohealth Holdings
Market Cap: HK$1.6b
Provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally.
2361
HK$3.94
7D
-3.4%
1Y
-12.2%
Rici Healthcare Holdings
Market Cap: HK$1.6b
Operates as an investment holding company that operates general hospitals, medical examination centers, medical laboratories, and clinics in the People’s Republic of China.
1526
HK$1.02
7D
2.0%
1Y
-18.4%
Arrail Group
Market Cap: HK$1.1b
Operates dental clinics and hospitals in China.
6639
HK$1.99
7D
-0.5%
1Y
-38.2%
Modern Dental Group
Market Cap: HK$4.9b
An investment holding company, engages in production, distribution, and trading of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally.
3600
HK$5.21
7D
-1.7%
1Y
49.7%
YSB
Market Cap: HK$7.0b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$10.27
7D
-9.4%
1Y
49.5%
Acotec Scientific Holdings
Market Cap: HK$3.7b
Operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.
6669
HK$11.76
7D
-8.1%
1Y
58.5%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$6.5b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease.
2291
HK$18.85
7D
-8.7%
1Y
6.0%
Kangji Medical Holdings
Market Cap: HK$10.9b
An investment holding company, designs, develops, manufactures, and sells minimally invasive surgical instruments and accessories in Mainland China and internationally.
9997
HK$9.02
7D
0.4%
1Y
53.1%
China Resources Medical Holdings
Market Cap: HK$4.5b
An investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People’s Republic of China.
1515
HK$3.45
7D
-1.1%
1Y
-8.0%
SAINT BELLA
Market Cap: HK$3.9b
Provides postpartum care and recovery services in the Cayman Islands, Hong Kong, Singapore, and China.
2508
HK$6.25
7D
-7.4%
1Y
n/a